Substance / Medication

Thymol

Overview

Active Ingredient
thymol
RxNorm CUI
10553

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

63 trials linked to this intervention

63
Total Trials
5
Recruiting
21
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Pharmaco-toxicological aspects of thymol in veterinary medicine. A systematic review.
Pérez Gaudio Denisa, Giantin Mery, Pauletto Marianna et al. · Front Vet Sci · 2025
PMID: 40874206Meta-AnalysisFull text (PMC)
Thymol and carvacrol against: anti-bacterial, anti-biofilm, and synergistic activities-a systematic review.
Farhadi Kousha, Rajabi Erta, Varpaei Hesam Aldin et al. · Front Pharmacol · 2024
PMID: 39512827Meta-AnalysisFull text (PMC)
Thymolipomatous myasthenia gravis outcomes following thymectomy: a systematic review.
Alghamdi Zeead M, Othman Sharifah A, Abdelmotaleb Mohammed Sabry et al. · Interact Cardiovasc Thorac Surg · 2022
PMID: 35362060Meta-AnalysisFull text (PMC)
Effects of Carvacrol, Thymol and essential oils containing such monoterpenes on wound healing: a systematic review.
Costa Michelle Fonseca, Durço Aimée Obolari, Rabelo Thallita Kelly et al. · J Pharm Pharmacol · 2019
PMID: 30537169Meta-Analysis
Thyme (Thymus vulgaris L.), thymol.
Basch Ethan, Ulbricht Catherine, Hammerness Paul et al. · J Herb Pharmacother · 2004
PMID: 15273078Meta-Analysis
Psychophysiological Analysis of Thymoleptic Effects of Xenon in Humans.
Aftanas L I, Bazanova O M, Khabarov A N et al. · Bull Exp Biol Med · 2020
PMID: 32651812RCT
Pharmacokinetic analysis of thymol, carvacrol and diallyl disulfide after intramammary and topical applications in healthy organic dairy cattle.
Mason Sharon E, Mullen Keena A E, Anderson Kevin L et al. · Food Addit Contam Part A Chem Anal Control Expo Risk Assess · 2017
PMID: 28277182RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Thymol (substance)
SNOMED CT
54932001
UMLS CUI
C0040096
RxNorm CUI
10553

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
63
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Thymol — Conditions, Biomarkers & Specialists | Healos | Ltrl